Loading…

Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients

ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient global assessment (PGA) >1/10 (a condition often designated as near-remission). This study aimed to assess which domains of impact could explain an elevated PGA in near-remission patients. We performed an ancilla...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2017-09, Vol.56 (9), p.1573-1578
Main Authors: Ferreira, Ricardo J O, Dougados, Maxime, Kirwan, John R, Duarte, Cátia, de Wit, Maarten, Soubrier, Martin, Fautrel, Bruno, Kvien, Tore K, da Silva, José A P, Gossec, Laure
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843
cites cdi_FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843
container_end_page 1578
container_issue 9
container_start_page 1573
container_title Rheumatology (Oxford, England)
container_volume 56
creator Ferreira, Ricardo J O
Dougados, Maxime
Kirwan, John R
Duarte, Cátia
de Wit, Maarten
Soubrier, Martin
Fautrel, Bruno
Kvien, Tore K
da Silva, José A P
Gossec, Laure
description ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient global assessment (PGA) >1/10 (a condition often designated as near-remission). This study aimed to assess which domains of impact could explain an elevated PGA in near-remission patients. We performed an ancillary analysis of data from three cross-sectional studies in patients with established RA. Three disease activity states were defined: remission (tender and swollen joint counts, CRP and PGA all ⩽1), near-remission (tender and swollen joint counts, and CRP are all ≤1 but PGA >1) and non-remission. Physical and psychological domains were assessed using the RA Impact of Disease 0-10 (numeric rating scale) as explanatory factors of PGA. Univariable and multivariable linear regression analyses were performed to explain PGA. A total of 1588 patients (79.1% females) were analysed. The mean disease duration was 13.0 years (s.d. 9.8) and the 28-joint DAS with four variables was 3.2 (s.d. 1.4). Near-remission [mean PGA 3.6 (s.d. 1.9)] was more frequent (19.1%) than remission (12.3%). Scores of RA Impact of Disease domains were similar in near-remission and non-remission patients. In near-remission, PGA was explained (R2adjusted = 0.55) by pain (β = 0.29), function (β = 0.23), physical well-being (β = 0.19) and fatigue (β = 0.15). Near-remission was more frequent than remission. These patients, despite having no signs of significant inflammation, report an impact of disease similar to the non-remission patients. PGA in near-remission seems to be driven by physical rather than psychological domains. Selecting the best therapy for these patients requires a better understanding of the meaning of PGA, both globally and in individual patients.
doi_str_mv 10.1093/rheumatology/kex211
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1936160454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1936160454</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843</originalsourceid><addsrcrecordid>eNpNUMlOwzAQtRCIlsIXICEfuZR6iVOHGyqrVIkLnCMnGbeGJC4eF-iZHyeli5BGmuXNmzd6hJxzdsVZJkdhDsvGRF_72Wr0Dt-C8wPS50kqhkxKcbivRdIjJ4hvjDHFpT4mPaG1yqRQffJzG9wnBKTe0oWJDtpIZ7UvTE0NIiA264lrdyDSLxfndKftKmpCnAcXXYfMfdcBLWuPQKOnARqH6Hx7TU3bhalX6P6kuNJ6f_KUHFlTI5xt84C83t-9TB6H0-eHp8nNdFhKxeLQjlUpQJTArRBMVDaxpaiUSCtZiEonIk0NVKzKuMo6mBUmSyEFza0dF1onckAuN3cXwX8sAWPevVdCXZsW_BJznsmUpyxR61W5WS2DRwxg80VwjQmrnLN87X7-3_18437HutgKLIsGqj1nZ7f8BdMiiDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1936160454</pqid></control><display><type>article</type><title>Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Ferreira, Ricardo J O ; Dougados, Maxime ; Kirwan, John R ; Duarte, Cátia ; de Wit, Maarten ; Soubrier, Martin ; Fautrel, Bruno ; Kvien, Tore K ; da Silva, José A P ; Gossec, Laure</creator><creatorcontrib>Ferreira, Ricardo J O ; Dougados, Maxime ; Kirwan, John R ; Duarte, Cátia ; de Wit, Maarten ; Soubrier, Martin ; Fautrel, Bruno ; Kvien, Tore K ; da Silva, José A P ; Gossec, Laure ; CoimbRA investigators, RAID investigators and COMEDRA investigators ; on behalf of the CoimbRA investigators, RAID investigators and COMEDRA investigators</creatorcontrib><description>ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient global assessment (PGA) &gt;1/10 (a condition often designated as near-remission). This study aimed to assess which domains of impact could explain an elevated PGA in near-remission patients. We performed an ancillary analysis of data from three cross-sectional studies in patients with established RA. Three disease activity states were defined: remission (tender and swollen joint counts, CRP and PGA all ⩽1), near-remission (tender and swollen joint counts, and CRP are all ≤1 but PGA &gt;1) and non-remission. Physical and psychological domains were assessed using the RA Impact of Disease 0-10 (numeric rating scale) as explanatory factors of PGA. Univariable and multivariable linear regression analyses were performed to explain PGA. A total of 1588 patients (79.1% females) were analysed. The mean disease duration was 13.0 years (s.d. 9.8) and the 28-joint DAS with four variables was 3.2 (s.d. 1.4). Near-remission [mean PGA 3.6 (s.d. 1.9)] was more frequent (19.1%) than remission (12.3%). Scores of RA Impact of Disease domains were similar in near-remission and non-remission patients. In near-remission, PGA was explained (R2adjusted = 0.55) by pain (β = 0.29), function (β = 0.23), physical well-being (β = 0.19) and fatigue (β = 0.15). Near-remission was more frequent than remission. These patients, despite having no signs of significant inflammation, report an impact of disease similar to the non-remission patients. PGA in near-remission seems to be driven by physical rather than psychological domains. Selecting the best therapy for these patients requires a better understanding of the meaning of PGA, both globally and in individual patients.</description><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kex211</identifier><identifier>PMID: 28859325</identifier><language>eng</language><publisher>England</publisher><subject>Adaptation, Psychological ; Adult ; Aged ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - psychology ; Biomarkers - blood ; C-Reactive Protein - metabolism ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Patient Reported Outcome Measures ; Remission Induction ; Severity of Illness Index ; Stress, Psychological - etiology</subject><ispartof>Rheumatology (Oxford, England), 2017-09, Vol.56 (9), p.1573-1578</ispartof><rights>The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843</citedby><cites>FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28859325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreira, Ricardo J O</creatorcontrib><creatorcontrib>Dougados, Maxime</creatorcontrib><creatorcontrib>Kirwan, John R</creatorcontrib><creatorcontrib>Duarte, Cátia</creatorcontrib><creatorcontrib>de Wit, Maarten</creatorcontrib><creatorcontrib>Soubrier, Martin</creatorcontrib><creatorcontrib>Fautrel, Bruno</creatorcontrib><creatorcontrib>Kvien, Tore K</creatorcontrib><creatorcontrib>da Silva, José A P</creatorcontrib><creatorcontrib>Gossec, Laure</creatorcontrib><creatorcontrib>CoimbRA investigators, RAID investigators and COMEDRA investigators</creatorcontrib><creatorcontrib>on behalf of the CoimbRA investigators, RAID investigators and COMEDRA investigators</creatorcontrib><title>Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient global assessment (PGA) &gt;1/10 (a condition often designated as near-remission). This study aimed to assess which domains of impact could explain an elevated PGA in near-remission patients. We performed an ancillary analysis of data from three cross-sectional studies in patients with established RA. Three disease activity states were defined: remission (tender and swollen joint counts, CRP and PGA all ⩽1), near-remission (tender and swollen joint counts, and CRP are all ≤1 but PGA &gt;1) and non-remission. Physical and psychological domains were assessed using the RA Impact of Disease 0-10 (numeric rating scale) as explanatory factors of PGA. Univariable and multivariable linear regression analyses were performed to explain PGA. A total of 1588 patients (79.1% females) were analysed. The mean disease duration was 13.0 years (s.d. 9.8) and the 28-joint DAS with four variables was 3.2 (s.d. 1.4). Near-remission [mean PGA 3.6 (s.d. 1.9)] was more frequent (19.1%) than remission (12.3%). Scores of RA Impact of Disease domains were similar in near-remission and non-remission patients. In near-remission, PGA was explained (R2adjusted = 0.55) by pain (β = 0.29), function (β = 0.23), physical well-being (β = 0.19) and fatigue (β = 0.15). Near-remission was more frequent than remission. These patients, despite having no signs of significant inflammation, report an impact of disease similar to the non-remission patients. PGA in near-remission seems to be driven by physical rather than psychological domains. Selecting the best therapy for these patients requires a better understanding of the meaning of PGA, both globally and in individual patients.</description><subject>Adaptation, Psychological</subject><subject>Adult</subject><subject>Aged</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - psychology</subject><subject>Biomarkers - blood</subject><subject>C-Reactive Protein - metabolism</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Reported Outcome Measures</subject><subject>Remission Induction</subject><subject>Severity of Illness Index</subject><subject>Stress, Psychological - etiology</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpNUMlOwzAQtRCIlsIXICEfuZR6iVOHGyqrVIkLnCMnGbeGJC4eF-iZHyeli5BGmuXNmzd6hJxzdsVZJkdhDsvGRF_72Wr0Dt-C8wPS50kqhkxKcbivRdIjJ4hvjDHFpT4mPaG1yqRQffJzG9wnBKTe0oWJDtpIZ7UvTE0NIiA264lrdyDSLxfndKftKmpCnAcXXYfMfdcBLWuPQKOnARqH6Hx7TU3bhalX6P6kuNJ6f_KUHFlTI5xt84C83t-9TB6H0-eHp8nNdFhKxeLQjlUpQJTArRBMVDaxpaiUSCtZiEonIk0NVKzKuMo6mBUmSyEFza0dF1onckAuN3cXwX8sAWPevVdCXZsW_BJznsmUpyxR61W5WS2DRwxg80VwjQmrnLN87X7-3_18437HutgKLIsGqj1nZ7f8BdMiiDA</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Ferreira, Ricardo J O</creator><creator>Dougados, Maxime</creator><creator>Kirwan, John R</creator><creator>Duarte, Cátia</creator><creator>de Wit, Maarten</creator><creator>Soubrier, Martin</creator><creator>Fautrel, Bruno</creator><creator>Kvien, Tore K</creator><creator>da Silva, José A P</creator><creator>Gossec, Laure</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170901</creationdate><title>Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients</title><author>Ferreira, Ricardo J O ; Dougados, Maxime ; Kirwan, John R ; Duarte, Cátia ; de Wit, Maarten ; Soubrier, Martin ; Fautrel, Bruno ; Kvien, Tore K ; da Silva, José A P ; Gossec, Laure</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adaptation, Psychological</topic><topic>Adult</topic><topic>Aged</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - psychology</topic><topic>Biomarkers - blood</topic><topic>C-Reactive Protein - metabolism</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Reported Outcome Measures</topic><topic>Remission Induction</topic><topic>Severity of Illness Index</topic><topic>Stress, Psychological - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, Ricardo J O</creatorcontrib><creatorcontrib>Dougados, Maxime</creatorcontrib><creatorcontrib>Kirwan, John R</creatorcontrib><creatorcontrib>Duarte, Cátia</creatorcontrib><creatorcontrib>de Wit, Maarten</creatorcontrib><creatorcontrib>Soubrier, Martin</creatorcontrib><creatorcontrib>Fautrel, Bruno</creatorcontrib><creatorcontrib>Kvien, Tore K</creatorcontrib><creatorcontrib>da Silva, José A P</creatorcontrib><creatorcontrib>Gossec, Laure</creatorcontrib><creatorcontrib>CoimbRA investigators, RAID investigators and COMEDRA investigators</creatorcontrib><creatorcontrib>on behalf of the CoimbRA investigators, RAID investigators and COMEDRA investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreira, Ricardo J O</au><au>Dougados, Maxime</au><au>Kirwan, John R</au><au>Duarte, Cátia</au><au>de Wit, Maarten</au><au>Soubrier, Martin</au><au>Fautrel, Bruno</au><au>Kvien, Tore K</au><au>da Silva, José A P</au><au>Gossec, Laure</au><aucorp>CoimbRA investigators, RAID investigators and COMEDRA investigators</aucorp><aucorp>on behalf of the CoimbRA investigators, RAID investigators and COMEDRA investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>56</volume><issue>9</issue><spage>1573</spage><epage>1578</epage><pages>1573-1578</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Undefined-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><abstract>ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient global assessment (PGA) &gt;1/10 (a condition often designated as near-remission). This study aimed to assess which domains of impact could explain an elevated PGA in near-remission patients. We performed an ancillary analysis of data from three cross-sectional studies in patients with established RA. Three disease activity states were defined: remission (tender and swollen joint counts, CRP and PGA all ⩽1), near-remission (tender and swollen joint counts, and CRP are all ≤1 but PGA &gt;1) and non-remission. Physical and psychological domains were assessed using the RA Impact of Disease 0-10 (numeric rating scale) as explanatory factors of PGA. Univariable and multivariable linear regression analyses were performed to explain PGA. A total of 1588 patients (79.1% females) were analysed. The mean disease duration was 13.0 years (s.d. 9.8) and the 28-joint DAS with four variables was 3.2 (s.d. 1.4). Near-remission [mean PGA 3.6 (s.d. 1.9)] was more frequent (19.1%) than remission (12.3%). Scores of RA Impact of Disease domains were similar in near-remission and non-remission patients. In near-remission, PGA was explained (R2adjusted = 0.55) by pain (β = 0.29), function (β = 0.23), physical well-being (β = 0.19) and fatigue (β = 0.15). Near-remission was more frequent than remission. These patients, despite having no signs of significant inflammation, report an impact of disease similar to the non-remission patients. PGA in near-remission seems to be driven by physical rather than psychological domains. Selecting the best therapy for these patients requires a better understanding of the meaning of PGA, both globally and in individual patients.</abstract><cop>England</cop><pmid>28859325</pmid><doi>10.1093/rheumatology/kex211</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2017-09, Vol.56 (9), p.1573-1578
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_miscellaneous_1936160454
source Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adaptation, Psychological
Adult
Aged
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - psychology
Biomarkers - blood
C-Reactive Protein - metabolism
Cross-Sectional Studies
Female
Humans
Male
Middle Aged
Patient Reported Outcome Measures
Remission Induction
Severity of Illness Index
Stress, Psychological - etiology
title Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T05%3A23%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drivers%20of%20patient%20global%20assessment%20in%20patients%20with%20rheumatoid%20arthritis%20who%20are%20close%20to%20remission:%20an%20analysis%20of%201588%20patients&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Ferreira,%20Ricardo%20J%20O&rft.aucorp=CoimbRA%20investigators,%20RAID%20investigators%20and%20COMEDRA%20investigators&rft.date=2017-09-01&rft.volume=56&rft.issue=9&rft.spage=1573&rft.epage=1578&rft.pages=1573-1578&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kex211&rft_dat=%3Cproquest_cross%3E1936160454%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-f75c2e2ce1f2202df4fc2d526d3b2d84266aed0d915902d0ba96e6e81ff7b8843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1936160454&rft_id=info:pmid/28859325&rfr_iscdi=true